High-density lipoprotein subclass profile and mortality in patients with coronary artery disease: Results from the

Meyer Elbaz1, Julien Faccini2, Vanina Bongard3

  • 1Inserm UMR-1048, Institute of Metabolic and Cardiovascular Diseases, 1, avenue Jean-Poulhès, 31432 Toulouse, France; Toulouse University Paul-Sabatier, 31062 Toulouse, France; Department of Cardiology, CHU de Toulouse, 31432 Toulouse, France.

Insights

High-density lipoprotein (HDL) subclasses do not predict mortality in coronary artery disease (CAD) patients. Other factors like heart rate and ejection fraction are more significant predictors of outcomes in CAD.

Area of Science:

  • Cardiovascular Medicine
  • Lipidology
  • Clinical Chemistry

Background:

  • High-density lipoproteins (HDLs) are heterogeneous, with subclass contributions to coronary artery disease (CAD) outcomes debated.
  • Current understanding of HDL subclass impact on clinical prognosis in CAD is limited.

Purpose of the Study:

  • To investigate the association between HDL subclass profiles and mortality risk in patients with established CAD.
  • To utilize a novel electrophoretic method for quantitative assessment of HDL particle size phenotypes.

Main Methods:

  • A cohort of 403 CAD patients underwent cardiovascular evaluation.
  • HDL subclass distribution was analyzed using the Quantimetrix Lipoprint® HDL system.
  • Kaplan-Meier and Cox proportional hazards regression analyses assessed survival and risk factors.

Main Results:

  • Mortality rate was 31.0% over 9.8 years, with 60.8% of deaths CAD-related.
  • No significant differences in total HDL cholesterol or small, intermediate, and large HDL subclasses were found between deceased and alive patients.
  • Heart rate, left ventricular ejection fraction, and coronary atherosclerosis severity were stronger predictors of mortality than HDL subclasses or total HDL cholesterol.

Conclusions:

  • The HDL subclass profile does not appear to be associated with mortality in patients with CAD.
  • Further research is needed to explore the role of HDL subclasses in predicting residual cardiovascular risk.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
794
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
73
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
558
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
740
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
868